Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kang E–H et al. – The authors found greater treatment response rate (defined as >=50% reduction in headache index) in patients with biofeedback–assisted autogenic training than in monitoring group. The scores on the anxiety and depression scales in the patients receiving biofeedback–assisted autogenic training decreased after the biofeedback treatment. Moreover, the decrease in their anxiety levels was significantly related to the treatment outcome. This result suggests that the biofeedback–assisted autogenic training is effective for the treatment of migraine and its therapeutic effect is closely related to the improvement of the anxiety level.

Related Articles

Food combinations key to acid reflux
Internet Source, 10/08/09    Relevance Score: 79%

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 69%

CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09    Relevance Score: 68%

Controversies in migraine
Nurse Prescribing, 10/09/09    Relevance Score: 68%

New drugs for migraine
The Journal of Headache and Pain, 10/05/09    Relevance Score: 68%

Today in Neurology...keeping you current

The Prevalence of Multiple Sclerosis in 3 US Communities
Preventing Chronic Disease, 12/16/09

Spontaneous Hyperventilation and Brain Tissue Hypoxia in Patients with Severe Brain Injury
Journal of Neurology, Neurosurgery, and Psychiatry , 12/16/09

Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve
Brain, 12/16/09

Today in Pain Management...keeping you current

Ulnar-sided wrist pain. II. Clinical imaging and treatment
Skeletal Radiology, 12/16/09

Intermittent Cancer Pain: Clinical Importance and an Updated Cancer Pain Classification
American Journal of Hospice and Palliative Medicine, 12/16/09

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/16/09

Today in Psychiatry...keeping you current

Genetics: Schizophrenia
Canadian Family Physician, 12/16/09

Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09

The APOE gene and cognitive function in non-demented and Alzheimers disease patients
Reviews in Clinical Gerontology, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address